| P/E (FY) | — | Sales (TTM) | €4.7M |
| Earnings (TTM) | -€18.5M | ROE | −24.77% |
| Net Margin | −393.37% | ROIC | −93.27% |
| Debt / Equity | 0.00 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
Nightingale Health Oyj is a health technology company offering health checks that detect the risks of common chronic diseases in Finland, the United Kingdom, the rest of Europe, the United States, and internationally. Its Health Check analyzes a single blood sample, and a Remote Health Check version is performed remotely, alongside blood and urine analysis, self-collection kits, and biomarker services. The company serves research programs, universities, and healthcare providers and is headquartered in Helsinki, Finland.
| Market Cap | — | Trading Days | 1298 |
| 52W High | 2.90 |
| 52W Low | 0.79 |
| % Off High | −70.90% |
| YTD | −58.83% | 1Y | −66.10% |
| 3Y | −1.63% | 5Y | −84.60% |
| Since incept. (ann.) | −28.64% |
| Ann. Volatility (1Y) | 51.31% | Ann. Volatility (3Y) | 64.13% |
| Sharpe (1Y) | −1.94 | Sharpe (3Y) | 0.30 |
| Max Drawdown (1Y) | −70.41% | Max Drawdown (3Y) | −80.63% |
| Beta (3Y, vs SPY) | −1.14 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.09T | 50.3 |
| JNJ | JOHNSON & JOHNSON | $616.50B | 23.2 |
| ONC | BeOne Medicines Ltd. | $465.49B | 1695.2 |
| ABBV | AbbVie Inc. | $454.79B | 109.1 |
| MRK | Merck & Co., Inc. | $320.56B | 17.8 |
| AMGN | AMGEN INC | $209.21B | 27.2 |
| ABT | ABBOTT LABORATORIES | $183.95B | 28.4 |
| GILD | GILEAD SCIENCES, INC. | $162.99B | 19.4 |
| PFE | PFIZER INC | $141.97B | 18.3 |
| SYK | STRYKER CORP | $133.42B | 41.4 |
| BMY | BRISTOL MYERS SQUIBB CO | $132.49B | 18.7 |
| ISRG | INTUITIVE SURGICAL INC | $124.70B | 44.9 |
